Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: HEMATOLOGICAL MALIGNANCY, . Treffer: 11
2022
Egger, M; Gornicec, M; Wölfler, A; Lembeck, AL; Tinchon, C; Maderdonner, M; Prattes, J
Incidence of invasive fungal infections in patients with hematological malignancies receiving ibrutinib therapy in south-east Austria.
Med Mycol. 2022; 60(9):
Doi: 10.1093/mmy/myac061
Web of Science
PubMed
FullText
FullText_MUG
2021
Jenks, JD; Prattes, J; Frank, J; Spiess, B; Mehta, SR; Boch, T; Buchheidt, D; Hoenigl, M
Performance of the Bronchoalveolar Lavage Fluid Aspergillus Galactomannan Lateral Flow Assay With Cube Reader for Diagnosis of Invasive Pulmonary Aspergillosis: A Multicenter Cohort Study.
Clin Infect Dis. 2021; 73(7):e1737-e1744
Doi: 10.1093/cid/ciaa1281
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Lin, WY; Fordham, SE; Hungate, E; Sunter, NJ; Elstob, C; Xu, Y; Park, C; Quante, A; Strauch, K; Gieger, C; Skol, A; Rahman, T; Sucheston-Campbell, L; Wang, J; Hahn, T; Clay-Gilmour, AI; Jones, GL; Marr, HJ; Jackson, GH; Menne, T; Collin, M; Ivey, A; Hills, RK; Burnett, AK; Russell, NH; Fitzgibbon, J; Larson, RA; Le, Beau, MM; Stock, W; Heidenreich, O; Alharbi, A; Allsup, DJ; Houlston, RS; Norden, J; Dickinson, AM; Douglas, E; Lendrem, C; Daly, AK; Palm, L; Piechocki, K; Jeffries, S; Bornhäuser, M; Röllig, C; Altmann, H; Ruhnke, L; Kunadt, D; Wagenführ, L; Cordell, HJ; Darlay, R; Andersen, MK; Fontana, MC; Martinelli, G; Marconi, G; Sanz, MA; Cervera, J; Gómez-Seguí, I; Cluzeau, T; Moreilhon, C; Raynaud, S; Sill, H; Voso, MT; Lo-Coco, F; Dombret, H; Cheok, M; Preudhomme, C; Gale, RE; Linch, D; Gaal-Wesinger, J; Masszi, A; Nowak, D; Hofmann, WK; Gilkes, A; Porkka, K; Milosevic, Feenstra, JD; Kralovics, R; Grimwade, D; Meggendorfer, M; Haferlach, T; Krizsán, S; Bödör, C; Stölzel, F; Onel, K; Allan, JM
Genome-wide association study identifies susceptibility loci for acute myeloid leukemia.
Nat Commun. 2021; 12(1): 6233
Doi: 10.1038/s41467-021-26551-x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2019
Rawlings, SA; Heldt, S; Prattes, J; Eigl, S; Jenks, JD; Flick, H; Rabensteiner, J; Prüller, F; Wölfler, A; Neumeister, P; Strohmaier, H; Krause, R; Hoenigl, M
Using Interleukin 6 and 8 in Blood and Bronchoalveolar Lavage Fluid to Predict Survival in Hematological Malignancy Patients With Suspected Pulmonary Mold Infection.
Front Immunol. 2019; 10(2):1798-1798
Doi: 10.3389/fimmu.2019.01798
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2018
Heldt, S; Prattes, J; Eigl, S; Spiess, B; Flick, H; Rabensteiner, J; Johnson, G; Prüller, F; Wölfler, A; Niedrist, T; Boch, T; Neumeister, P; Strohmaier, H; Krause, R; Buchheidt, D; Hoenigl, M
Diagnosis of invasive aspergillosis in hematological malignancy patients: Performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples.
J Infect. 2018; 77(3):235-241
Doi: 10.1016/j.jinf.2018.05.001
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2016
Juric, MK; Shevtsov, M; Mozes, P; Ogonek, J; Crossland, RE; Dickinson, AM; Greinix, HT; Holler, E; Weissinger, EM; Multhoff, G
B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Front Immunol. 2016; 7(3):660-660
Doi: 10.3389/fimmu.2016.00660
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2014
Duettmann, W; Koidl, C; Troppan, K; Seeber, K; Buzina, W; Wölfler, A; Wagner, J; Krause, R; Hoenigl, M
Serum and urine galactomannan testing for screening in patients with hematological malignancies.
Med Mycol. 2014; 52(6):647-652
Doi: 10.1093/mmy/myu019
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2013
Hoenigl, M; Duettmann, W; Raggam, RB; Seeber, K; Troppan, K; Fruhwald, S; Prueller, F; Wagner, J; Valentin, T; Zollner-Schwetz, I; Wölfler, A; Krause, R
Potential factors for inadequate voriconazole plasma concentrations in intensive care unit patients and patients with hematological malignancies.
Antimicrob Agents Chemother. 2013; 57(7):3262-3267
Doi: 10.1128/AAC.00251-13
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2012
Hoenigl, M; Salzer, HJ; Raggam, RB; Valentin, T; Rohn, A; Woelfler, A; Seeber, K; Linkesch, W; Krause, R
Impact of galactomannan testing on the prevalence of invasive aspergillosis in patients with hematological malignancies.
Med Mycol. 2012; 50(3):266-269
Doi: 10.3109/13693786.2011.603102
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2000
Harousseau, JL; Dekker, AW; Stamatoullas-Bastard, A; Fassas, A; Linkesch, W; Gouveia, J; De Bock, R; Rovira, M; Seifert, WF; Joosen, H; Peeters, M; De Beule, K
Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B.
Antimicrob Agents Chemother. 2000; 44(7):1887-1893
Doi: 10.1128%2FAAC.44.7.1887-1893.2000
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
1995
Kalhs, P; Brugger, S; Schwarzinger, I; Greinix, HT; Keil, F; Kyrle, PA; Knöbl, P; Schneider, B; Höcker, P; Linkesch, W
Microangiopathy following allogeneic marrow transplantation. Association with cyclosporine and methylprednisolone for graft-versus-host disease prophylaxis.
Transplantation. 1995; 60(9):949-957
Doi: 10.1097/00007890-199511150-00012
Web of Science
PubMed
FullText
FullText_MUG